Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk Jila Kaberi OtarodIra J. Goldberg OriginalPaper Pages: 335 - 342
Hepatic lipase: Friend or foe and under what circumstances? Hans Jansen OriginalPaper Pages: 343 - 347
Low-density lipoprotein reduction in high-risk patients: How low do you go? Peter P. Toth OriginalPaper Pages: 348 - 352
ASCOT-LLA and the primary prevention of coronary artery disease in hypertensive patients Vijay NambiChristie M. Ballantyne OriginalPaper Pages: 353 - 358
High-density lipoprotein subfractions and risk of coronary artery disease John MorganChristina CareyDavid Capuzzi OriginalPaper Pages: 359 - 365
Lessons learned from the prospective pravastatin pooling project Robert P. ByingtonFrank M. Sacks OriginalPaper Pages: 366 - 374
ALLHAT-LLT: Questions, questions, and more questions (and some answers) Patrick J. SkerrettRichard C. Pasternak OriginalPaper Pages: 375 - 380
Low-density lipoprotein particle number and risk for cardiovascular disease William C. CromwellJames D. Otvos OriginalPaper Pages: 381 - 387
Evidence-based treatment of lipids in the elderly Micah J. EimerNeil J. Stone OriginalPaper Pages: 388 - 397
Inhibition of cholesteryl ester transfer protein activity: A new therapeutic approach to raising high-density lipoprotein Daniel J. Rader OriginalPaper Pages: 398 - 405